We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

ADVANCED INSTRUMENTS

Advanced Instruments designs, manufactures and markets laboratory products for the clinical, food and dairy, microbio... read more Featured Products: More products

Download Mobile App





Advanced Instruments Introduces New Automated Osmometer at AACC 2022

By LabMedica International staff writers
Posted on 27 Jul 2022
Print article
Image: OsmoPRO MAX Automated Osmometer (Photo courtesy of Advanced Instruments)
Image: OsmoPRO MAX Automated Osmometer (Photo courtesy of Advanced Instruments)

A new osmometer delivers the automation and data management capabilities modern clinical labs require to free up tech time, improve result turnaround times, reduce errors, and ensure effortless compliance.

Advanced Instruments, LLC (Norwood, MA, USA) announced the newest addition to its clinical line of freezing point osmometers, the OsmoPRO MAX Automated Osmometer, at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo. The OsmoPRO MAX has been designed for clinical laboratories of all sizes seeking higher productivity through automation. The instrument's innovative flow-through technology eliminates manual pipetting and consumables, allowing testing to begin with the push of a button.

The OsmoPRO MAX goes beyond providing accurate and precise test results to deliver a fully automated solution. It uses the industry-preferred freezing point depression method to provide reliable results in minutes. The instrument provides increased efficiency and a simplified osmolality testing workflow:

  • Direct sampling from primary tubes eliminates the need for sample cups.
  • Continuous loading of samples in their primary tubes as they arrive minimizes workflow interruptions and eliminates batch testing.
  • Ready-to-use system fluid automates cleaning between samples for up to 500 tests.
  • Automated barcode scanning reduces transcription errors and prevents sample mix-ups.
  • Automatic data upload capability to the AdvancedQC peer group program facilitates monitoring of quality control trends and instrument performance.

"The OsmoPRO MAX delivers the ease of use, automation, and data management features today's clinical laboratories seek," said Byron Selman, CEO of Advanced Instruments. "Advanced Instruments continues to innovate in the field of osmometry while remaining committed to the product quality and reliability that our customers have depended on for the past 65 years."

Related Links:
Advanced Instruments, LLC 

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
New
Mycobacterium Tuberculosis Test
Allplex MTB/MDRe Detection
New
MTHFR Mutation Test
REALQUALITY THROMBO MTHFR

Print article

Channels

Molecular Diagnostics

view channel
Image: Umbilical cord blood biomarkers may improve preterm infant care (Photo courtesy of Shutterstock)

Umbilical Cord Blood Test Could Identify Preterm Infants at Risk for Medical Complications

Advancements in medical technology and neonatology have significantly improved the care of prematurely born infants. However, these infants still face heightened risks for medical complications, such as... Read more

Immunology

view channel

3D Bioprinted Gastric Cancer Model Uses Patient-Derived Tissue Fragments to Predict Drug Response

Tumor heterogeneity presents a major obstacle in the development and treatment of cancer therapies, as patients' responses to the same drug can differ, and the timing of treatment significantly influences prognosis. Consequently, technologies that predict the effectiveness of anticancer treatments are essential in minimizing... Read more

Microbiology

view channel
Image: The Cytovale System isolates, images, and analyzes cells (Photo courtesy of Cytovale)

Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application

Sepsis is the leading cause of death and the most expensive condition treated in U.S. hospitals. The risk of death from sepsis increases by up to 8% for each hour that treatment is delayed, making early... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.